PITAVASTATIN

PITAVASTATIN was reported 10341 times

PITAVASTATIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GNATHOSCHISIS 2 0.2222
1 AMAUROSIS FUGAX 228 0.2117
2 ARTERIAL REVASCULARISATION 2 0.1333
3 VISCERAL PAIN 6 0.0652
4 GASTRIC DYSPLASIA 3 0.0638
5 LUNG ADENOCARCINOMA STAGE II 2 0.0588
6 CHOLERA 2 0.0513
7 URINARY TRACT DISORDER 198 0.0439
8 JOINT DEPOSIT 2 0.0426
9 GAMMA-GLUTAMYLTRANSFERASE 4 0.0367
10 HAEMORRHAGIC STROKE 250 0.0320
11 COMBINED PULMONARY FIBROSIS AND EMPHYSEMA 2 0.0282
12 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 6 0.0258
13 PROTHROMBIN TIME RATIO INCREASED 5 0.0230
14 MERYCISM 6 0.0210
15 OCULAR DISCOMFORT 231 0.0206
16 FAILURE TO SUSPEND MEDICATION 4 0.0193
17 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 2 0.0180
18 JOINT TUBERCULOSIS 2 0.0179
19 RECURRENCE OF NEUROMUSCULAR BLOCKADE 3 0.0175
20 CEREBRAL VASCULAR OCCLUSION 2 0.0174
21 VULVOVAGINAL INFLAMMATION 8 0.0174
22 GINGIVAL OEDEMA 3 0.0170
23 GENERALISED OEDEMA 208 0.0168
24 INFECTIVE SPONDYLITIS 4 0.0166
25 GASTROINTESTINAL DYSPLASIA 2 0.0165
26 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 4 0.0148
27 INSULIN C-PEPTIDE INCREASED 2 0.0144
28 IMMOBILISATION SYNDROME 3 0.0141
29 INCLUSION BODY MYOSITIS 2 0.0133
30 HEAD DISCOMFORT 230 0.0130
31 ALTERED STATE OF CONSCIOUSNESS 262 0.0121
32 CORONAVIRUS PNEUMONIA 2 0.0120
33 EMBOLIC CEREBRAL INFARCTION 7 0.0106
34 ADRENAL ADENOMA 6 0.0101
35 SACRAL PAIN 6 0.0099
36 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 2 0.0097
37 HAEMATEMESIS 237 0.0093
38 CREATINE KINASE INCREASED 7 0.0091
39 PHOTOPHOBIA 168 0.0089
40 THROMBOPHLEBITIS MIGRANS 3 0.0088
41 CD4 LYMPHOCYTES INCREASED 2 0.0086
42 IMMUNE-MEDIATED MYOSITIS 23 0.0083
43 PRESYNCOPE 198 0.0081
44 ASCITES 230 0.0078
45 DIPLOPIA 200 0.0077
46 EYE HAEMATOMA 2 0.0076
47 PULMONARY SEPSIS 11 0.0076
48 LIPIDS ABNORMAL 5 0.0069
49 MYOCARDIAL RUPTURE 2 0.0066
50 LOW DENSITY LIPOPROTEIN ABNORMAL 4 0.0065
51 HAEMATURIA 223 0.0065
52 PERIPHERAL ARTERY STENOSIS 3 0.0063
53 LYMPHOCYTE STIMULATION TEST POSITIVE 5 0.0062
54 DYSBIOSIS 5 0.0061
55 HEAT ILLNESS 4 0.0059
56 CARDIO-RESPIRATORY ARREST 245 0.0059
57 CONJUNCTIVITIS BACTERIAL 2 0.0058
58 HAEMORRHAGIC CEREBRAL INFARCTION 4 0.0057
59 BLINDNESS 231 0.0057
60 LIP EROSION 4 0.0055
61 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 6 0.0054
62 DIABETIC KETOSIS 2 0.0053
63 BONE TUBERCULOSIS 2 0.0052
64 LIPID METABOLISM DISORDER 2 0.0052
65 LYMPHOCYTE MORPHOLOGY ABNORMAL 3 0.0052
66 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 3 0.0051
67 NEUROPSYCHOLOGICAL SYMPTOMS 3 0.0050
68 COMA 227 0.0048
69 TINNITUS 218 0.0047
70 NECROTISING MYOSITIS 4 0.0046
71 TOXIC ENCEPHALOPATHY 23 0.0045
72 CONGESTIVE HEPATOPATHY 2 0.0045
73 MACULAR FIBROSIS 3 0.0044
74 AKINESIA 9 0.0043
75 EYE PAIN 235 0.0042
76 IMMUNE-MEDIATED THYROIDITIS 2 0.0040
77 AUTOIMMUNE PANCREATITIS 2 0.0040
78 PEMPHIGOID 29 0.0038
79 SINUS NODE DYSFUNCTION 7 0.0038
80 GOUTY ARTHRITIS 3 0.0038
81 HEART FAILURE WITH REDUCED EJECTION FRACTION 2 0.0037
82 CHRONIC HEPATITIS 3 0.0037
83 RENAL ABSCESS 3 0.0037
84 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0036
85 PERIPHERAL ARTERY OCCLUSION 5 0.0036
86 MECHANICAL ILEUS 2 0.0035
87 CARDIAC DISCOMFORT 7 0.0035
88 THALAMUS HAEMORRHAGE 3 0.0034
89 DYSPNOEA AT REST 10 0.0034
90 HYPOPITUITARISM 6 0.0034
91 CELLULITIS ORBITAL 2 0.0034
92 MALIGNANT PERITONEAL NEOPLASM 2 0.0034
93 FEAR OF DISEASE 6 0.0034
94 CORONARY ARTERY RESTENOSIS 2 0.0033
95 DYSLIPIDAEMIA 17 0.0033
96 UPPER RESPIRATORY TRACT INFLAMMATION 4 0.0033
97 SECONDARY ADRENOCORTICAL INSUFFICIENCY 5 0.0033
98 BRONCHITIS CHRONIC 8 0.0033
99 MYOPATHY 28 0.0032
100 MUSCLE ABSCESS 2 0.0032
101 CHOLINERGIC SYNDROME 2 0.0031
102 PYELONEPHRITIS ACUTE 6 0.0031
103 EXTRADURAL HAEMATOMA 4 0.0030
104 CARDIAC FAILURE ACUTE 20 0.0030
105 CUTANEOUS SYMPTOM 2 0.0029
106 NON-ALCOHOLIC STEATOHEPATITIS 3 0.0029
107 ANGULAR CHEILITIS 2 0.0029
108 URETEROLITHIASIS 3 0.0029
109 BONE DEMINERALISATION 3 0.0028
110 FANCONI SYNDROME 4 0.0028
111 BILE DUCT STONE 9 0.0028
112 TACHYCARDIA 250 0.0028
113 DRUG-DISEASE INTERACTION 2 0.0027
114 PHYSICAL DECONDITIONING 7 0.0027
115 MYALGIA 459 0.0027
116 BLISTER RUPTURE 2 0.0027
117 CARCINOID TUMOUR 2 0.0027
118 HYPERURICAEMIA 11 0.0027
119 SMALL INTESTINAL PERFORATION 5 0.0027
120 ADRENAL DISORDER 5 0.0026
121 COAGULATION TIME PROLONGED 4 0.0026
122 IMMUNE-MEDIATED HEPATIC DISORDER 5 0.0026
123 BLOOD KETONE BODY INCREASED 2 0.0026
124 URINE KETONE BODY PRESENT 4 0.0025
125 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
126 HEAT EXHAUSTION 2 0.0025
127 IMMUNE-MEDIATED MYOCARDITIS 4 0.0025
128 CEREBRAL ARTERY EMBOLISM 3 0.0025
129 ORAL MUCOSA EROSION 3 0.0024
130 HEPATIC FUNCTION ABNORMAL 91 0.0024
131 PNEUMONIA BACTERIAL 22 0.0024
132 HYPERCHOLESTEROLAEMIA 23 0.0024
133 CONTRAINDICATED PRODUCT PRESCRIBED 4 0.0024
134 TROPONIN T INCREASED 3 0.0024
135 CARDIAC FAILURE CHRONIC 10 0.0023
136 FEMORAL NECK FRACTURE 12 0.0023
137 RADIATION PNEUMONITIS 5 0.0023
138 CORONARY ARTERY DISSECTION 2 0.0023
139 IATROGENIC INJURY 3 0.0023
140 ARTERIAL STENOSIS 2 0.0023
141 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 2 0.0023
142 DIABETIC NEPHROPATHY 5 0.0023
143 BRAIN NATRIURETIC PEPTIDE INCREASED 7 0.0023
144 POLYMYOSITIS 4 0.0023
145 ENTEROCOLITIS 13 0.0022
146 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
147 SEPSIS 248 0.0022
148 BLOOD MAGNESIUM INCREASED 2 0.0022
149 ANORGASMIA 6 0.0022
150 SYNCOPE 221 0.0022
151 SIALOADENITIS 3 0.0022
152 CONDUCTION DISORDER 4 0.0022
153 IMMUNE-MEDIATED ENTEROCOLITIS 8 0.0022
154 MYOSITIS 19 0.0021
155 CHILLS 245 0.0021
156 CANCER SURGERY 2 0.0021
157 CEREBRAL INFARCTION 51 0.0021
158 DISCOLOURED VOMIT 2 0.0021
159 GALLBLADDER CANCER 3 0.0020
160 RHINITIS ALLERGIC 9 0.0020
161 DIPLEGIA 4 0.0020
162 STEROID DIABETES 3 0.0020
163 SMALL INTESTINAL HAEMORRHAGE 4 0.0020
164 AUTONOMIC NEUROPATHY 2 0.0020
165 INFECTIOUS PLEURAL EFFUSION 3 0.0020
166 DIVERTICULAR PERFORATION 4 0.0019
167 FULMINANT TYPE 1 DIABETES MELLITUS 2 0.0019
168 SPINAL STENOSIS 8 0.0019
169 ABSCESS JAW 2 0.0019
170 COLITIS MICROSCOPIC 9 0.0019
171 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
172 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3 0.0019
173 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 2 0.0019
174 KIDNEY ENLARGEMENT 2 0.0018
175 CLAUSTROPHOBIA 2 0.0018
176 PANIC DISORDER 7 0.0018
177 BLOOD CREATINE PHOSPHOKINASE INCREASED 52 0.0018
178 GASTROINTESTINAL ULCER 4 0.0018
179 CORONARY ARTERY STENOSIS 9 0.0018
180 DIVERTICULUM INTESTINAL HAEMORRHAGIC 4 0.0018
181 CHRONIC GASTRITIS 4 0.0018
182 GASTRIC POLYPS 4 0.0018
183 DUODENAL ULCER HAEMORRHAGE 5 0.0017
184 VASCULAR PSEUDOANEURYSM 3 0.0017
185 STRESS CARDIOMYOPATHY 10 0.0017
186 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 7 0.0017
187 EMBOLIC STROKE 6 0.0017
188 HYPERTENSIVE EMERGENCY 2 0.0017
189 EUGLYCAEMIC DIABETIC KETOACIDOSIS 7 0.0017
190 INTERSTITIAL LUNG DISEASE 82 0.0017
191 HAEMORRHAGE SUBCUTANEOUS 6 0.0017
192 BILE DUCT CANCER 2 0.0017
193 COMPRESSION FRACTURE 9 0.0017
194 ODYNOPHAGIA 10 0.0017
195 LACUNAR INFARCTION 4 0.0017
196 THYROIDITIS 5 0.0017
197 GRANULOMATOSIS WITH POLYANGIITIS 2 0.0017
198 LIP OEDEMA 7 0.0017
199 HEPATIC PAIN 7 0.0016
200 GLOMERULONEPHRITIS 4 0.0016
201 ANURIA 14 0.0016
202 BLOOD PRESSURE INCREASED 242 0.0016
203 LIP HAEMORRHAGE 2 0.0016
204 SKIN EROSION 5 0.0016
205 BLOOD CHLORIDE DECREASED 4 0.0015
206 HIGH DENSITY LIPOPROTEIN DECREASED 5 0.0015
207 NEUROGENIC BLADDER 3 0.0014
208 PULMONARY TOXICITY 10 0.0014
209 GLOMERULAR FILTRATION RATE ABNORMAL 2 0.0014
210 PYELONEPHRITIS 12 0.0014
211 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
212 HYPOTHALAMO-PITUITARY DISORDER 2 0.0014
213 VISION BLURRED 188 0.0014
214 AMYLASE INCREASED 5 0.0014
215 COMPLEX REGIONAL PAIN SYNDROME 2 0.0014
216 DRUG ERUPTION 24 0.0014
217 MYASTHENIA GRAVIS CRISIS 2 0.0013
218 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
219 CHOLANGIOCARCINOMA 2 0.0013
220 ANGIOPLASTY 2 0.0013
221 BRAIN HERNIATION 4 0.0013
222 BLOOD LACTATE DEHYDROGENASE INCREASED 21 0.0013
223 DISTRIBUTIVE SHOCK 3 0.0013
224 AGE-RELATED MACULAR DEGENERATION 2 0.0013
225 MARASMUS 2 0.0013
226 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
227 DECREASED APPETITE 301 0.0013
228 RHABDOMYOLYSIS 54 0.0013
229 PNEUMONIA ASPIRATION 32 0.0013
230 ARTERIOSCLEROSIS 12 0.0013
231 POLYMYALGIA RHEUMATICA 4 0.0013
232 IGA NEPHROPATHY 2 0.0012
233 PROTEIN URINE PRESENT 6 0.0012
234 GASTROINTESTINAL PERFORATION 5 0.0012
235 GASTRIC DILATATION 2 0.0012
236 HYPERPARATHYROIDISM SECONDARY 3 0.0012
237 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
238 SUBDURAL HAEMATOMA 17 0.0012
239 RETINAL ARTERY OCCLUSION 3 0.0012
240 ERYTHEMA MULTIFORME 11 0.0012
241 ENTERITIS INFECTIOUS 2 0.0012
242 CANCER PAIN 3 0.0012
243 LACTOSE INTOLERANCE 3 0.0012
244 TENSION HEADACHE 5 0.0012
245 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
246 GASTROINTESTINAL OEDEMA 2 0.0011
247 ASPARTATE AMINOTRANSFERASE INCREASED 60 0.0011
248 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25 0.0011
249 AORTIC VALVE STENOSIS 2 0.0011
250 SOMNOLENCE 223 0.0011
251 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
252 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
253 DRUG INTERACTION 174 0.0011
254 HAEMOGLOBIN INCREASED 5 0.0011
255 SPINAL COMPRESSION FRACTURE 9 0.0011
256 DISORGANISED SPEECH 2 0.0011
257 DRUG-INDUCED LIVER INJURY 34 0.0011
258 HEPATITIS ACUTE 7 0.0011
259 ANGINA UNSTABLE 7 0.0011
260 CARDIAC DYSFUNCTION 4 0.0011
261 BLOOD CHOLESTEROL DECREASED 2 0.0011
262 HYDRONEPHROSIS 8 0.0011
263 INADEQUATE ANALGESIA 9 0.0011
264 CHOLECYSTITIS ACUTE 6 0.0011
265 AUTOIMMUNE THYROIDITIS 4 0.0011
266 PANCREATIC CARCINOMA METASTATIC 3 0.0011
267 HYPOPROTEINAEMIA 2 0.0011
268 CARDIAC TAMPONADE 5 0.0011
269 TUMOUR HAEMORRHAGE 3 0.0011
270 C-REACTIVE PROTEIN INCREASED 38 0.0010
271 ESCHERICHIA SEPSIS 3 0.0010
272 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
273 CARCINOEMBRYONIC ANTIGEN INCREASED 2 0.0010
274 GLYCOSYLATED HAEMOGLOBIN INCREASED 26 0.0010
275 ABDOMINAL PAIN UPPER 212 0.0010
276 DRUG LEVEL INCREASED 17 0.0010
277 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
278 HYPERTRIGLYCERIDAEMIA 6 0.0010
279 BICYTOPENIA 2 0.0010
280 HYPOGLYCAEMIC UNCONSCIOUSNESS 2 0.0010
281 CELL DEATH 2 0.0010
282 AUTOIMMUNE HEPATITIS 7 0.0010
283 OESOPHAGEAL CANDIDIASIS 4 0.0010
284 ABDOMINAL PAIN 233 0.0010
285 OROPHARYNGEAL DISCOMFORT 9 0.0010
286 TRANSAMINASES INCREASED 22 0.0010
287 HYPERTENSIVE CRISIS 11 0.0010
288 PERIPHERAL ISCHAEMIA 4 0.0010
289 ALANINE AMINOTRANSFERASE INCREASED 60 0.0010
290 CHOLANGITIS 6 0.0010
291 ACUTE CORONARY SYNDROME 8 0.0010
292 VENTRICULAR EXTRASYSTOLES 10 0.0010
293 SQUAMOUS CELL CARCINOMA 9 0.0010
294 INSOMNIA 254 0.0010
295 RENAL IMPAIRMENT 80 0.0010
296 ORTHOPNOEA 3 0.0009
297 VENTRICULAR HYPOKINESIA 3 0.0009
298 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
299 METABOLIC ACIDOSIS 29 0.0009
300 GINGIVAL SWELLING 4 0.0009
301 LIVER DISORDER 40 0.0009
302 HYPOCALCAEMIA 17 0.0009
303 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
304 HAEMARTHROSIS 8 0.0009
305 LARGE INTESTINAL HAEMORRHAGE 2 0.0009
306 COUGH 248 0.0009
307 METASTASES TO MENINGES 2 0.0009
308 DERMATITIS ALLERGIC 11 0.0009
309 NEPHROGENIC ANAEMIA 4 0.0009
310 SHOCK HAEMORRHAGIC 7 0.0009
311 CAROTID ARTERY STENOSIS 3 0.0009
312 JAUNDICE CHOLESTATIC 3 0.0008
313 BLOOD TRIGLYCERIDES INCREASED 15 0.0008
314 ACUTE MYOCARDIAL INFARCTION 25 0.0008
315 FALL 282 0.0008
316 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 5 0.0008
317 FIBRIN D DIMER INCREASED 3 0.0008
318 PYREXIA 290 0.0008
319 BLOOD UREA INCREASED 14 0.0008
320 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
321 EYE OEDEMA 2 0.0008
322 ORGANISING PNEUMONIA 4 0.0008
323 HYPERNATRAEMIA 4 0.0008
324 HEPATIC ENZYME ABNORMAL 4 0.0008
325 CYTOKINE RELEASE SYNDROME 16 0.0008
326 SPINAL OSTEOARTHRITIS 7 0.0008
327 PROTEIN TOTAL DECREASED 3 0.0008
328 LUNG INFILTRATION 7 0.0008
329 DIABETIC KETOACIDOSIS 19 0.0008
330 DERMATOMYOSITIS 2 0.0008
331 TONGUE OEDEMA 3 0.0008
332 HYPOTHYROIDISM 25 0.0008
333 ENTERITIS 5 0.0008
334 ENDOCARDITIS 4 0.0008
335 DRUG TITRATION ERROR 2 0.0008
336 EYELID OEDEMA 9 0.0008
337 RHINOVIRUS INFECTION 3 0.0008
338 ACTINIC KERATOSIS 2 0.0008
339 HERNIA REPAIR 2 0.0008
340 RESPIRATORY TRACT INFECTION 20 0.0008
341 HEPATITIS TOXIC 2 0.0008
342 COMPARTMENT SYNDROME 2 0.0008
343 AFFECTIVE DISORDER 6 0.0008
344 CARDIAC FAILURE 61 0.0008
345 BLOOD LACTIC ACID INCREASED 4 0.0008
346 IDIOPATHIC PULMONARY FIBROSIS 3 0.0008
347 PRURITUS 290 0.0008
348 MUSCLE RIGIDITY 9 0.0008
349 HYPERLACTACIDAEMIA 2 0.0007
350 BLOOD SODIUM INCREASED 2 0.0007
351 HYPERKALAEMIA 26 0.0007
352 COLON CANCER 11 0.0007
353 NEUTROPHIL COUNT DECREASED 30 0.0007
354 DIABETES MELLITUS INADEQUATE CONTROL 13 0.0007
355 ANGINA PECTORIS 21 0.0007
356 HYPERAESTHESIA 6 0.0007
357 HYPERCALCAEMIA 9 0.0007
358 AORTIC DISSECTION 3 0.0007
359 LARGE INTESTINE POLYP 5 0.0007
360 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
361 PAPULE 5 0.0007
362 ATYPICAL FEMUR FRACTURE 2 0.0007
363 DUODENAL ULCER 5 0.0007
364 MUSCLE FATIGUE 3 0.0007
365 LIP PAIN 2 0.0007
366 SHOCK 16 0.0007
367 ASTHENIA 261 0.0007
368 HYPOGLYCAEMIC COMA 2 0.0007
369 HYPERTONIC BLADDER 2 0.0007
370 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
371 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
372 DIVERTICULUM INTESTINAL 3 0.0007
373 ORAL CANDIDIASIS 9 0.0007
374 COVID-19 PNEUMONIA 8 0.0007
375 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
376 HEPATITIS FULMINANT 2 0.0007
377 BACTERAEMIA 8 0.0007
378 ARTHRALGIA 280 0.0007
379 ILEUS PARALYTIC 3 0.0007
380 CHOLECYSTITIS 8 0.0007
381 QUALITY OF LIFE DECREASED 9 0.0007
382 SYMPTOM RECURRENCE 4 0.0007
383 MALAISE 292 0.0007
384 HEPATITIS CHOLESTATIC 4 0.0007
385 JOINT DISLOCATION 7 0.0007
386 TACHYPNOEA 9 0.0007
387 CRANIOCEREBRAL INJURY 2 0.0007
388 EMBOLISM VENOUS 2 0.0007
389 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
390 DERMATITIS ACNEIFORM 4 0.0007
391 IMMUNE THROMBOCYTOPENIA 3 0.0007
392 DIABETIC FOOT 2 0.0007
393 FACE OEDEMA 11 0.0007
394 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
395 BLOOD CREATININE DECREASED 2 0.0006
396 DYSPNOEA EXERTIONAL 24 0.0006
397 BLOOD ALBUMIN DECREASED 5 0.0006
398 HEPATOTOXICITY 14 0.0006
399 EOSINOPHILIA 11 0.0006
400 NON-SMALL CELL LUNG CANCER 3 0.0006
401 DIZZINESS 311 0.0006
402 DRUG INTOLERANCE 60 0.0006
403 LIVER ABSCESS 2 0.0006
404 MYOCARDIAL ISCHAEMIA 7 0.0006
405 HYPOVENTILATION 2 0.0006
406 INTERNAL HAEMORRHAGE 7 0.0006
407 SPRUE-LIKE ENTEROPATHY 3 0.0006
408 LISTLESS 2 0.0006
409 HEMIPLEGIA 5 0.0006
410 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
411 ANXIETY DISORDER 2 0.0006
412 COLITIS ISCHAEMIC 4 0.0006
413 HYPOTHERMIA 6 0.0006
414 HEPATIC STEATOSIS 11 0.0006
415 SUBARACHNOID HAEMORRHAGE 6 0.0006
416 DIABETIC RETINOPATHY 2 0.0006
417 BRONCHOPNEUMONIA 2 0.0006
418 APLASIA PURE RED CELL 2 0.0006
419 TENDONITIS 9 0.0006
420 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
421 ENCEPHALITIS 4 0.0006
422 BASAL CELL CARCINOMA 9 0.0006
423 ADRENAL INSUFFICIENCY 7 0.0006
424 LARGE INTESTINE PERFORATION 4 0.0006
425 HYPERTRANSAMINASAEMIA 4 0.0006
426 HYPOMAGNESAEMIA 8 0.0006
427 FEBRILE NEUTROPENIA 38 0.0006
428 RIGHT VENTRICULAR FAILURE 4 0.0006
429 SERUM FERRITIN INCREASED 3 0.0006
430 LYMPHOCYTE COUNT DECREASED 10 0.0006
431 ANAL FISTULA 3 0.0006
432 RETINAL HAEMORRHAGE 4 0.0006
433 JAUNDICE 15 0.0006
434 HYPOGLYCAEMIA 27 0.0006
435 ANAL ABSCESS 3 0.0006
436 DIARRHOEA 359 0.0006
437 LUPUS-LIKE SYNDROME 5 0.0006
438 HYDROCEPHALUS 3 0.0006
439 FAECES SOFT 4 0.0005
440 HYPERGLYCAEMIA 20 0.0005
441 MELAENA 12 0.0005
442 ALCOHOL USE 2 0.0005
443 DYSPNOEA 305 0.0005
444 ACUTE PULMONARY OEDEMA 3 0.0005
445 ENCEPHALOPATHY 13 0.0005
446 LACTIC ACIDOSIS 17 0.0005
447 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
448 VOMITING 246 0.0005
449 CORONARY ARTERY BYPASS 3 0.0005
450 HYPOKALAEMIA 24 0.0005
451 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
452 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
453 BLOOD CHOLESTEROL INCREASED 24 0.0005
454 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
455 HYPOVOLAEMIA 3 0.0005
456 EPIGASTRIC DISCOMFORT 2 0.0005
457 CERVIX CARCINOMA 2 0.0005
458 PLEURISY 3 0.0005
459 RENAL CYST 4 0.0005
460 TRANSPLANT REJECTION 4 0.0005
461 ARTERIOSPASM CORONARY 2 0.0005
462 TYPE 1 DIABETES MELLITUS 3 0.0005
463 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
464 EYELID PTOSIS 5 0.0005
465 GOITRE 2 0.0005
466 HICCUPS 4 0.0005
467 TENDON RUPTURE 6 0.0005
468 CONJUNCTIVITIS 9 0.0005
469 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
470 HEADACHE 301 0.0005
471 BLOOD CREATININE INCREASED 31 0.0005
472 SUDDEN DEATH 5 0.0005
473 ANAEMIA 90 0.0005
474 BRADYCARDIA 25 0.0005
475 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
476 AORTIC VALVE INCOMPETENCE 2 0.0005
477 HEPATIC LESION 2 0.0005
478 CONTRAINDICATED PRODUCT ADMINISTERED 14 0.0005
479 CORONARY ARTERY DISEASE 14 0.0005
480 PLEURAL EFFUSION 28 0.0005
481 URINE OUTPUT DECREASED 4 0.0005
482 PRODUCT COMMUNICATION ISSUE 4 0.0005
483 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
484 DYSARTHRIA 17 0.0005
485 MENINGITIS 3 0.0004
486 CHRONIC KIDNEY DISEASE 34 0.0004
487 BRONCHIECTASIS 3 0.0004
488 PANCREATITIS ACUTE 10 0.0004
489 IRON DEFICIENCY 2 0.0004
490 ARRHYTHMIA 21 0.0004
491 MITRAL VALVE INCOMPETENCE 5 0.0004
492 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
493 PRODUCTIVE COUGH 21 0.0004
494 NEPHROTIC SYNDROME 3 0.0004
495 SKIN LESION 12 0.0004
496 SEPTIC SHOCK 19 0.0004
497 MOVEMENT DISORDER 14 0.0004
498 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
499 FEELING OF DESPAIR 2 0.0004
500 APPENDICITIS 4 0.0004
501 PLATELET COUNT DECREASED 45 0.0004
502 CYTOMEGALOVIRUS INFECTION 7 0.0004
503 HYPERLIPIDAEMIA 5 0.0004
504 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
505 GRAFT VERSUS HOST DISEASE 3 0.0004
506 GASTROINTESTINAL TOXICITY 2 0.0004
507 DERMATITIS BULLOUS 3 0.0004
508 DEHYDRATION 55 0.0004
509 GASTROENTERITIS 6 0.0004
510 RENAL DISORDER 19 0.0004
511 DYSURIA 15 0.0004
512 HYPOPHOSPHATAEMIA 3 0.0004
513 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
514 OEDEMA 22 0.0004
515 STEVENS-JOHNSON SYNDROME 9 0.0004
516 INFLAMMATORY MARKER INCREASED 2 0.0004
517 MUSCLE SPASMS 74 0.0004
518 BLOOD PRESSURE ABNORMAL 8 0.0004
519 ILEUS 5 0.0004
520 FLUID INTAKE REDUCED 2 0.0004
521 ACUTE KIDNEY INJURY 61 0.0004
522 TOXIC SKIN ERUPTION 4 0.0004
523 EMPHYSEMA 4 0.0004
524 DRUG TOLERANCE 2 0.0004
525 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
526 BLOOD PRESSURE DECREASED 26 0.0004
527 HYPOPHAGIA 10 0.0004
528 NEUTROPHIL COUNT INCREASED 4 0.0004
529 CEREBRAL ISCHAEMIA 2 0.0004
530 NAUSEA 306 0.0004
531 OSTEOMYELITIS 7 0.0004
532 HYPOALBUMINAEMIA 3 0.0004
533 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
534 FATIGUE 300 0.0004
535 PNEUMOTHORAX 6 0.0004
536 OEDEMA PERIPHERAL 46 0.0004
537 GINGIVAL PAIN 3 0.0004
538 POOR QUALITY SLEEP 8 0.0004
539 GAIT DISTURBANCE 71 0.0004
540 FRACTURE 7 0.0004
541 FAECES DISCOLOURED 8 0.0004
542 POST PROCEDURAL INFECTION 3 0.0004
543 OESOPHAGITIS 4 0.0004
544 CORONARY ARTERY OCCLUSION 5 0.0004
545 ACUTE RESPIRATORY FAILURE 7 0.0004
546 VENTRICULAR TACHYCARDIA 6 0.0004
547 CEREBRAL HAEMORRHAGE 13 0.0004
548 MUSCLE INJURY 3 0.0004
549 EMBOLISM 3 0.0004
550 GASTRIC ULCER HAEMORRHAGE 2 0.0004
551 VENTRICULAR FIBRILLATION 4 0.0004
552 CHOKING 7 0.0004
553 PANCYTOPENIA 20 0.0004
554 MALNUTRITION 4 0.0004
555 RASH PAPULAR 8 0.0004
556 NEPHROPATHY TOXIC 4 0.0004
557 BLOOD CALCIUM DECREASED 4 0.0004
558 HEPATIC ENZYME INCREASED 24 0.0004
559 ERECTILE DYSFUNCTION 9 0.0004
560 SKIN ULCER 9 0.0003
561 MOUTH SWELLING 2 0.0003
562 BLOOD URIC ACID INCREASED 2 0.0003
563 DELIRIUM 12 0.0003
564 HYPERTHYROIDISM 5 0.0003
565 HYPERVENTILATION 2 0.0003
566 BONE MARROW FAILURE 7 0.0003
567 NAIL DISORDER 3 0.0003
568 TUMOUR LYSIS SYNDROME 3 0.0003
569 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
570 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
571 ATRIAL FIBRILLATION 33 0.0003
572 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
573 BLOOD IRON DECREASED 4 0.0003
574 NEUROPATHY PERIPHERAL 32 0.0003
575 CARDIAC PACEMAKER INSERTION 2 0.0003
576 MUSCULAR WEAKNESS 38 0.0003
577 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
578 OSTEOPENIA 5 0.0003
579 NEURALGIA 8 0.0003
580 INGUINAL HERNIA 2 0.0003
581 DEVICE RELATED INFECTION 5 0.0003
582 LYMPHOMA 5 0.0003
583 PHARYNGITIS 4 0.0003
584 EXTRAPYRAMIDAL DISORDER 8 0.0003
585 NEPHROPATHY 3 0.0003
586 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
587 ANGIOEDEMA 14 0.0003
588 GASTRIC ULCER 6 0.0003
589 PROTEINURIA 6 0.0003
590 MALIGNANT NEOPLASM PROGRESSION 32 0.0003
591 PANCREATIC CARCINOMA 9 0.0003
592 TREATMENT NONCOMPLIANCE 17 0.0003
593 ANAPHYLACTIC SHOCK 8 0.0003
594 BLOOD POTASSIUM INCREASED 5 0.0003
595 PALPITATIONS 36 0.0003
596 ANHEDONIA 8 0.0003
597 PULMONARY CONGESTION 4 0.0003
598 PRESCRIBED UNDERDOSE 6 0.0003
599 VIRAL INFECTION 10 0.0003
600 COGNITIVE DISORDER 14 0.0003
601 PRODUCT ADMINISTRATION ERROR 6 0.0003
602 METASTASES TO LYMPH NODES 2 0.0003
603 BLOOD BILIRUBIN INCREASED 8 0.0003
604 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
605 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
606 LIMB INJURY 8 0.0003
607 EPILEPSY 9 0.0003
608 MOTOR DYSFUNCTION 3 0.0003
609 OSTEOPOROSIS 12 0.0003
610 RIB FRACTURE 6 0.0003
611 PERITONITIS 6 0.0003
612 HYPERBILIRUBINAEMIA 3 0.0003
613 PULMONARY HYPERTENSION 6 0.0003
614 ORTHOSTATIC HYPOTENSION 5 0.0003
615 COLD SWEAT 5 0.0003
616 LYMPHOPENIA 4 0.0003
617 BODY HEIGHT DECREASED 3 0.0003
618 NEUTROPENIA 38 0.0003
619 LIVER FUNCTION TEST INCREASED 6 0.0003
620 CARDIOGENIC SHOCK 4 0.0003
621 HERPES ZOSTER 16 0.0003
622 PNEUMONIA 90 0.0003
623 CELLULITIS 14 0.0003
624 CHOLELITHIASIS 9 0.0003
625 END STAGE RENAL DISEASE 5 0.0003
626 RASH MACULO-PAPULAR 6 0.0003
627 KETOACIDOSIS 2 0.0003
628 CHROMATURIA 6 0.0003
629 ECONOMIC PROBLEM 4 0.0003
630 COLITIS 10 0.0003
631 HEPATOCELLULAR CARCINOMA 2 0.0003
632 MYOCARDITIS 3 0.0003
633 PROSTATE CANCER 21 0.0003
634 LIPASE INCREASED 2 0.0003
635 SEROTONIN SYNDROME 5 0.0003
636 ATRIOVENTRICULAR BLOCK 2 0.0003
637 PRESCRIBED OVERDOSE 5 0.0003
638 APHTHOUS ULCER 2 0.0003
639 POST PROCEDURAL HAEMORRHAGE 3 0.0003
640 LUNG INFECTION 4 0.0003
641 EJECTION FRACTION DECREASED 4 0.0003
642 GASTROINTESTINAL INFLAMMATION 2 0.0003
643 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
644 HAEMOPTYSIS 7 0.0003
645 HYPERTENSION 53 0.0002
646 DIABETES MELLITUS 19 0.0002
647 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
648 HYPONATRAEMIA 14 0.0002
649 RHINORRHOEA 16 0.0002
650 NOCTURIA 3 0.0002
651 ASPHYXIA 2 0.0002
652 CARDIOMEGALY 3 0.0002
653 OSTEONECROSIS OF JAW 6 0.0002
654 LOSS OF CONSCIOUSNESS 31 0.0002
655 INFUSION RELATED REACTION 16 0.0002
656 RENAL FAILURE 32 0.0002
657 LIVER FUNCTION TEST ABNORMAL 7 0.0002
658 EOSINOPHIL COUNT INCREASED 2 0.0002
659 PEMPHIGUS 3 0.0002
660 GAIT INABILITY 8 0.0002
661 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
662 ATRIAL SEPTAL DEFECT 2 0.0002
663 HAEMODIALYSIS 2 0.0002
664 GASTRIC CANCER 6 0.0002
665 URINARY INCONTINENCE 7 0.0002
666 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
667 HYPOTENSION 47 0.0002
668 BLOOD POTASSIUM DECREASED 7 0.0002
669 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
670 INFLAMMATION 12 0.0002
671 MUSCLE STRAIN 2 0.0002
672 SUICIDE ATTEMPT 14 0.0002
673 MUCOSAL INFLAMMATION 6 0.0002
674 FEMUR FRACTURE 7 0.0002
675 LUNG DISORDER 11 0.0002
676 ISCHAEMIC STROKE 4 0.0002
677 BACK PAIN 52 0.0002
678 FEAR 6 0.0002
679 PAIN OF SKIN 6 0.0002
680 URINARY TRACT INFECTION 38 0.0002
681 MYELOSUPPRESSION 8 0.0002
682 RESPIRATORY FAILURE 16 0.0002
683 PERIPHERAL COLDNESS 3 0.0002
684 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
685 IRON DEFICIENCY ANAEMIA 2 0.0002
686 DIVERTICULITIS 6 0.0002
687 POLLAKIURIA 9 0.0002
688 DEEP VEIN THROMBOSIS 14 0.0002
689 DEMENTIA 6 0.0002
690 BACTERIAL INFECTION 4 0.0002
691 OXYGEN SATURATION DECREASED 12 0.0002
692 FLANK PAIN 2 0.0002
693 SLEEP DISORDER 15 0.0002
694 ASTHMA 24 0.0002
695 MYOCARDIAL INFARCTION 37 0.0002
696 INTENTIONAL DOSE OMISSION 6 0.0002
697 SKIN DISORDER 7 0.0002
698 EYE INFLAMMATION 2 0.0002
699 SLEEP APNOEA SYNDROME 4 0.0002
700 HYPERSOMNIA 6 0.0002
701 CHOLESTASIS 4 0.0002
702 BLOOD PRESSURE FLUCTUATION 5 0.0002
703 LOWER LIMB FRACTURE 4 0.0002
704 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
705 SEIZURE 24 0.0002
706 ATELECTASIS 2 0.0002
707 DIZZINESS POSTURAL 2 0.0002
708 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
709 CHEST DISCOMFORT 21 0.0002
710 INTENTIONAL OVERDOSE 13 0.0002
711 HAEMATOCRIT DECREASED 4 0.0002
712 INABILITY TO AFFORD MEDICATION 2 0.0002
713 CARDIAC FAILURE CONGESTIVE 16 0.0002
714 HEPATIC FAILURE 6 0.0002
715 CONTUSION 19 0.0002
716 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
717 THROMBOCYTOPENIA 22 0.0002
718 FLUID RETENTION 10 0.0002
719 HEPATITIS 5 0.0002
720 MOBILITY DECREASED 14 0.0002
721 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
722 HELICOBACTER INFECTION 2 0.0002
723 FLATULENCE 11 0.0002
724 HYPOAESTHESIA 29 0.0002
725 THERAPY PARTIAL RESPONDER 3 0.0002
726 HEART RATE INCREASED 19 0.0002
727 INJECTION SITE DISCOMFORT 2 0.0002
728 MOUTH ULCERATION 4 0.0002
729 FULL BLOOD COUNT ABNORMAL 2 0.0002
730 CHEST PAIN 35 0.0002
731 OSTEOARTHRITIS 8 0.0002
732 OBESITY 3 0.0002
733 SENSORY DISTURBANCE 3 0.0002
734 IRRITABLE BOWEL SYNDROME 4 0.0002
735 INTESTINAL OBSTRUCTION 7 0.0002
736 DECREASED ACTIVITY 2 0.0002
737 ASPIRATION 2 0.0002
738 GASTROINTESTINAL PAIN 2 0.0002
739 CONDITION AGGRAVATED 55 0.0002
740 BLOOD GLUCOSE INCREASED 34 0.0002
741 URINARY RETENTION 6 0.0002
742 CONSTIPATION 39 0.0002
743 EYE PRURITUS 6 0.0002
744 TYPE 2 DIABETES MELLITUS 6 0.0002
745 CIRCULATORY COLLAPSE 3 0.0002
746 IMPAIRED DRIVING ABILITY 2 0.0002
747 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
748 CHOLECYSTECTOMY 2 0.0002
749 OFF LABEL USE 153 0.0002
750 METASTASES TO LUNG 2 0.0002
751 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
752 HEART RATE DECREASED 6 0.0002
753 GALLBLADDER DISORDER 3 0.0002
754 CATARACT 10 0.0002
755 ROAD TRAFFIC ACCIDENT 7 0.0002
756 RESPIRATORY DISORDER 5 0.0002
757 RASH PRURITIC 9 0.0002
758 TOXICITY TO VARIOUS AGENTS 28 0.0002
759 SINUSITIS 17 0.0002
760 LEUKOCYTOSIS 3 0.0002
761 HEPATITIS C 2 0.0002
762 APHASIA 5 0.0002
763 BONE DISORDER 3 0.0002
764 APPLICATION SITE IRRITATION 2 0.0002
765 INJECTION SITE DISCOLOURATION 2 0.0002
766 HEPATIC CIRRHOSIS 3 0.0002
767 BLOOD SODIUM DECREASED 3 0.0002
768 PARAESTHESIA 25 0.0002
769 FOOT FRACTURE 3 0.0002
770 ABDOMINAL PAIN LOWER 4 0.0002
771 INFLUENZA LIKE ILLNESS 13 0.0002
772 PULMONARY EMBOLISM 15 0.0002
773 EYE IRRITATION 9 0.0002
774 GASTROINTESTINAL DISORDER 14 0.0002
775 MYDRIASIS 2 0.0002
776 THERAPY NON-RESPONDER 7 0.0002
777 WEIGHT DECREASED 43 0.0002
778 DYSPHONIA 9 0.0002
779 ABDOMINAL DISTENSION 16 0.0002
780 DEAFNESS 4 0.0002
781 WEIGHT INCREASED 34 0.0002
782 DEPRESSED MOOD 8 0.0002
783 STOMATITIS 9 0.0001
784 COVID-19 26 0.0001
785 TASTE DISORDER 3 0.0001
786 DYSKINESIA 6 0.0001
787 HYPERHIDROSIS 19 0.0001
788 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
789 IMPAIRED GASTRIC EMPTYING 2 0.0001
790 GINGIVAL BLEEDING 2 0.0001
791 HALLUCINATION 11 0.0001
792 INFECTION 21 0.0001
793 HAEMATOCHEZIA 8 0.0001
794 RESPIRATORY DISTRESS 4 0.0001
795 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
796 NEOPLASM PROGRESSION 5 0.0001
797 HAEMORRHAGE 15 0.0001
798 INFLUENZA 16 0.0001
799 URTICARIA 24 0.0001
800 DERMATITIS 3 0.0001
801 BLISTER 8 0.0001
802 RASH 62 0.0001
803 LYMPHADENOPATHY 5 0.0001
804 HEPATOCELLULAR INJURY 2 0.0001
805 DIALYSIS 2 0.0001
806 BRONCHOSPASM 2 0.0001
807 LEUKOPENIA 7 0.0001
808 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
809 THERAPY CESSATION 7 0.0001
810 HAEMOGLOBIN DECREASED 14 0.0001
811 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
812 GLOSSODYNIA 3 0.0001
813 CARDIAC ARREST 11 0.0001
814 EMOTIONAL DISTRESS 16 0.0001
815 PRODUCT AVAILABILITY ISSUE 3 0.0001
816 ABDOMINAL DISCOMFORT 22 0.0001
817 GYNAECOMASTIA 4 0.0001
818 MUSCULOSKELETAL CHEST PAIN 2 0.0001
819 PRODUCT USE IN UNAPPROVED INDICATION 32 0.0001
820 SWOLLEN TONGUE 4 0.0001
821 BONE DENSITY DECREASED 4 0.0001
822 BALANCE DISORDER 11 0.0001
823 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
824 HALLUCINATION, AUDITORY 2 0.0001
825 CYSTITIS 4 0.0001
826 ABSCESS 2 0.0001
827 LOCALISED INFECTION 3 0.0001
828 MENTAL IMPAIRMENT 3 0.0001
829 FIBROMYALGIA 3 0.0001
830 DEPRESSION 28 0.0001
831 LIVER INJURY 3 0.0001
832 LUNG NEOPLASM MALIGNANT 5 0.0001
833 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
834 BONE PAIN 7 0.0001
835 PAIN 73 0.0001
836 CANDIDA INFECTION 2 0.0001
837 DRUG RESISTANCE 3 0.0001
838 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
839 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
840 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
841 RECTAL HAEMORRHAGE 5 0.0001
842 ANXIETY 33 0.0001
843 HAEMATOMA 3 0.0001
844 NIGHTMARE 4 0.0001
845 VERTIGO 7 0.0001
846 ECZEMA 6 0.0001
847 JOINT STIFFNESS 3 0.0001
848 ERYTHEMA 23 0.0001
849 PRODUCT USE ISSUE 21 0.0001
850 PULMONARY OEDEMA 5 0.0001
851 DRY MOUTH 9 0.0001
852 GASTROENTERITIS VIRAL 2 0.0001
853 PALLOR 3 0.0001
854 PNEUMONITIS 3 0.0001
855 UNDERDOSE 8 0.0001
856 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
857 RESPIRATORY ARREST 3 0.0001
858 PAIN IN EXTREMITY 32 0.0001
859 TREMOR 18 0.0001
860 BLOOD GLUCOSE ABNORMAL 2 0.0001
861 FEELING COLD 3 0.0001
862 DYSGEUSIA 8 0.0001
863 AGRANULOCYTOSIS 2 0.0001
864 NECK PAIN 6 0.0001
865 RHEUMATOID ARTHRITIS 12 0.0001
866 BLOOD URINE PRESENT 2 0.0001
867 RED BLOOD CELL COUNT DECREASED 3 0.0001
868 INCREASED APPETITE 2 0.0001
869 LETHARGY 6 0.0001
870 PERIPHERAL SWELLING 16 0.0001
871 GLAUCOMA 2 0.0001
872 DYSTONIA 2 0.0001
873 HAEMORRHOIDS 2 0.0001
874 HYPERSENSITIVITY 19 0.0001
875 NASAL CONGESTION 6 0.0001
876 OVERDOSE 22 0.0001
877 LABORATORY TEST ABNORMAL 3 0.0001
878 ABNORMAL BEHAVIOUR 4 0.0001
879 DRY EYE 5 0.0001
880 AGGRESSION 5 0.0001
881 LACRIMATION INCREASED 3 0.0001
882 FULL BLOOD COUNT DECREASED 2 0.0001
883 INTENTIONAL SELF-INJURY 2 0.0001
884 THERAPEUTIC RESPONSE DECREASED 6 0.0001
885 ILL-DEFINED DISORDER 6 0.0001
886 NERVOUS SYSTEM DISORDER 3 0.0001
887 BRONCHITIS 7 0.0001
888 RENAL FAILURE ACUTE 4 0.0001
889 EATING DISORDER 2 0.0001
890 EPISTAXIS 7 0.0001
891 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
892 OSTEONECROSIS 3 0.0001
893 STAPHYLOCOCCAL INFECTION 3 0.0001
894 APPLICATION SITE PAIN 2 0.0001
895 LIP SWELLING 3 0.0001
896 MEDICATION ERROR 5 0.0001
897 HEART RATE IRREGULAR 2 0.0001
898 SUICIDAL IDEATION 8 0.0001
899 MEMORY IMPAIRMENT 12 0.0001
900 NEPHROLITHIASIS 4 0.0001
901 RASH MACULAR 3 0.0001
902 SURGERY 5 0.0001
903 OCULAR HYPERAEMIA 4 0.0001
904 DYSPHAGIA 8 0.0001
905 THERAPY INTERRUPTED 6 0.0001
906 MIGRAINE 8 0.0001
907 IRRITABILITY 5 0.0001
908 SKIN EXFOLIATION 7 0.0001
909 INJECTION SITE URTICARIA 2 0.0001
910 NASOPHARYNGITIS 15 0.0001
911 INJECTION SITE MASS 3 0.0001
912 AGEUSIA 2 0.0001
913 MUSCULOSKELETAL STIFFNESS 7 0.0001
914 CARDIOVASCULAR DISORDER 2 0.0001
915 EXPOSURE VIA SKIN CONTACT 2 0.0001
916 PLASMA CELL MYELOMA 3 0.0001
917 AMNESIA 5 0.0001
918 MUSCULOSKELETAL PAIN 4 0.0001
919 DERMATITIS ATOPIC 4 0.0001
920 OROPHARYNGEAL PAIN 7 0.0001
921 DRY SKIN 10 0.0001
922 THROMBOSIS 6 0.0001
923 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
924 PSORIATIC ARTHROPATHY 3 0.0001
925 MOOD ALTERED 2 0.0001
926 ABNORMAL DREAMS 2 0.0001
927 TREATMENT FAILURE 6 0.0001
928 DRUG INEFFECTIVE 95 0.0001
929 BURNING SENSATION 5 0.0001
930 DEVICE MALFUNCTION 5 0.0001
931 DYSPEPSIA 7 0.0001
932 PRODUCT SUBSTITUTION ISSUE 4 0.0001
933 DYSSTASIA 2 0.0001
934 DISEASE PROGRESSION 8 0.0001
935 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
936 HOT FLUSH 5 0.0001
937 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
938 INJECTION SITE SWELLING 5 0.0001
939 INJECTION SITE RASH 2 0.0001
940 LIMB DISCOMFORT 2 0.0001
941 INJECTION SITE ERYTHEMA 8 0.0001
942 CARDIAC DISORDER 6 0.0001
943 HEAD INJURY 2 0.0001
944 FEELING ABNORMAL 15 0.0001
945 EYE DISORDER 2 0.0001
946 INJECTION SITE REACTION 4 0.0001
947 NERVOUSNESS 3 0.0001
948 INTENTIONAL PRODUCT MISUSE 5 0.0001
949 HYPOXIA 2 0.0001
950 PANCREATITIS 3 0.0001
951 ALOPECIA 11 0.0001
952 ANAPHYLACTIC REACTION 3 0.0001
953 EYE SWELLING 2 0.0001
954 CEREBROVASCULAR ACCIDENT 9 0.0001
955 ARTHRITIS 4 0.0001
956 DISORIENTATION 2 0.0001
957 FLUSHING 5 0.0000
958 DISCOMFORT 3 0.0000
959 FEELING HOT 3 0.0000
960 INJECTION SITE PAIN 15 0.0000
961 COMPLETED SUICIDE 4 0.0000
962 SWELLING FACE 3 0.0000
963 MENTAL DISORDER 2 0.0000
964 PRODUCT STORAGE ERROR 4 0.0000
965 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
966 DRUG WITHDRAWAL SYNDROME 4 0.0000
967 INJECTION SITE PRURITUS 3 0.0000
968 ADVERSE EVENT 4 0.0000
969 CONFUSIONAL STATE 7 0.0000
970 BREAST CANCER 4 0.0000
971 INJURY 3 0.0000
972 DISEASE RECURRENCE 2 0.0000
973 BLOOD GLUCOSE DECREASED 2 0.0000
974 UNEVALUABLE EVENT 3 0.0000
975 INCORRECT DOSE ADMINISTERED 9 0.0000
976 HOSPITALISATION 6 0.0000
977 ILLNESS 4 0.0000
978 INJECTION SITE BRUISING 3 0.0000
979 PRODUCT DOSE OMISSION ISSUE 11 0.0000
980 DRUG EFFECT DECREASED 2 0.0000
981 DEATH 31 0.0000
982 ARTHROPATHY 2 0.0000
983 BLADDER CANCER 2 0.0000
984 NO ADVERSE EVENT 6 0.0000
985 VISUAL IMPAIRMENT 4 0.0000
986 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
987 AGITATION 2 0.0000
988 ACNE 2 0.0000
989 JOINT SWELLING 3 0.0000
990 PSORIASIS 3 0.0000
991 ADVERSE DRUG REACTION 2 0.0000